• About us
  • People
    • 1 st funding period
  • Projects
    • 1 st funding period
  • Open Positions
  • Publications
  • Seminars

Blaeschke F, Ortner E, Stenger D, Mahdawi J, Apfelbeck A, Habjan N, Weißer T, Kaeuferle T, Willier S, Kobold S, Feuchtinger T. (2025) Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function.

by TUMbrandherde | Jun 4, 2025

Lorenzini T, Cadilha BL, Obeck H, Benmebarek MR, Märkl F, Michaelides S, Strzalkowski T, Briukhovetska D, Müller PJ, Nandi S, Winter P, Majed L, Grünmeier R, Seifert M, Rausch S, Feuchtinger T, Endres S, Kobold S. (2025) Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy.

by TUMbrandherde | Jun 4, 2025

Kobold, S. (2025) RORing CAR T Cells in Solid and Hematologic Cancers: Same but Different

by TUMbrandherde | Jun 4, 2025

Mestermann, K; Garitano-Trojaola, A; Hudecek, M. (2025) Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors

by TUMbrandherde | Jun 4, 2025

Schütz, B; Krause, FF; Taudte, RV; Zaiss, MM; Luu, M; Visekruna, A. (2025) Modulation of Host Immunity by Microbiome-Derived Indole-3-Propionic Acid and Other Bacterial Metabolites

by TUMbrandherde | Jun 4, 2025

« Older Entries

Recent Posts

  • LETSimmun enters its second funding period!
  • Joint publication by Matthias Feige and Kathrin Schumann
  • Joint publication by Ulrike Protzer and Matthias Feige
  • New publication of Marion Subklewe in Cancer Immunology Research
  • New publication by Veit Buchholz in nature

Recent Comments

  1. A WordPress Commenter on New publication on cytotoxic T cells in SARS-CoV2 infection
  • Contact
  • About Letsimmun
  • News
  • Open Positions
  • Follow
  • Follow
  • Privacy
  • Imprint
Developed by Sitegeek